SEC Form 4 · accession 0001225208-26-007811
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew M. Dahl
Officer — SVP, Corporate Controller
Period of report
Sep 13, 2026
Accepted (ET)
Sep 14, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 13, 2026 | F | 253 | $84.37 | D | 14,615 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.